| α-syn | Alpha-synuclein |
| Aβ | Amyloid-beta |
| AAO | Age at onset |
| ANK | Ankyrin domain |
| ARM | Armadillo domain |
| BDNF | Brain-derived neurotrophic factor |
| BST1 | Bone marrow stromal cell antigen 1 |
| CBD | Corticobasal degeneration |
| CD | Crohn’s disease |
| COR | C-terminal of ROC domain |
| DLB | Dementia with Lewy bodies |
| DNM3 | Dynamin-3 |
| ET | Essential Tremor |
| GAK | Cyclin-G-associated kinase |
| GBA | Glucosidase, beta, acid, or glucocerebrosidase |
| GCI | Glia cytoplasmic inclusions |
| GTP | Guanosine triphosphate |
| GWAS | Genome-wide association study |
| HRV | Heart-rate variability |
| IBD | Inflammatory bowel disease |
| iPD | Idiopathic Parkinson’s disease |
| iPSC | Induced pluripotent stem cells |
| LB | Lewy body |
| LBD | Lewy body disorder |
| LRR | Leucine-rich repeat domain |
| LRRK2 | Leucine-rich repeat kinase 2 |
| MAPT | Microtubule-associated protein tau |
| MRI | Magnetic resonance imaging |
| MSA | Multiple system atrophy |
| PD | Parkinson’s disease |
| PDD | Parkinson’s disease dementia |
| PSP | Progressive supranuclear palsy |
| PSP-P | Progressive supranuclear palsy parkinsonism |
| PRS | Polygenic risk score |
| REM | Rapid eye movement |
| Roc | Ras of complex proteins |
| SND | Substantia nigra degeneration |
| SNP | Single nucleotide polymorphism |
| TDP-43 | Transactive response DNA-binding protein 43 |
| VAMP4 | Vesicle-associated membrane protein 4 |
| VaP | Vascular parkinsonism |